Levetiracetam Mylan Generics (Levetiracetam)

Levetiracetam is an antiepileptic medication that modulates neuronal excitability to control seizure activity in the central nervous system.

• Partial‑onset seizures: Decreases frequency and intensity of focal seizures in patients with epilepsy, improving quality of life.
• Generalized tonic‑clonic seizures: Lowers the risk of convulsive episodes and improves overall seizure control, reducing hospitalizations.
• Myoclonic seizures: Reduces sudden muscle jerks, aiding stability and daily functioning for affected individuals.
• Adjunct therapy for refractory epilepsy: Provides additional seizure control when first‑line agents are insufficient.

• Levetiracetam binds to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This interaction modulates calcium‑dependent exocytosis, stabilizing neuronal membranes and reducing hyper‑synchronization of neuronal firing, which diminishes the propagation of epileptic discharges throughout the brain. The drug does not significantly affect GABA or glutamate receptor activity, and its effect is observed across various brain regions, contributing to broad‑spectrum seizure control.

Levetiracetam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Dizziness: Lightheadedness or unsteady feeling, especially when standing quickly.
• Fatigue: Persistent tiredness that may affect daily activities.
• Headache: Mild to moderate pain that can be intermittent.
• Irritability: Mood changes such as increased agitation or short temper.
• Nausea: Stomach discomfort or urge to vomit, often transient.

Serious or Rare Side Effects

• Severe allergic reaction: Rash, swelling, or difficulty breathing requiring immediate medical attention.
• Mood disorders: Depression, suicidal thoughts, or severe anxiety that may emerge during treatment.
• Hematologic abnormalities: Low blood cell counts (e.g., leukopenia, thrombocytopenia) increasing infection or bleeding risk.

Before prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

• Renal function: Adjust dose in patients with impaired kidney function.
• Psychiatric history: Monitor for new or worsening depression, anxiety, or suicidal thoughts.
• Pregnancy status: Evaluate risks and benefits, as safety data are limited.
• Concomitant CNS depressants: Use caution when combined with other sedating agents.
• Driving and machinery: Advise patients to assess personal response before operating vehicles or heavy equipment.
• Store at ambient temperature: Keep below 25 °C in original packaging, protected from moisture.

Levetiracetam can interact with other medicines, altering its effectiveness or increasing adverse effects.

Major Interactions (Avoid)

• Carbamazepine: May significantly reduce levetiracetam plasma concentrations, potentially diminishing seizure control.
• Phenobarbital: Can lower levetiracetam levels, increasing risk of breakthrough seizures.

Moderate Interactions (Monitor Closely)

• Alcohol: Concurrent use may enhance central nervous system depression, leading to increased drowsiness or dizziness.
• Other antiepileptics (e.g., valproate, phenytoin): May require dose adjustments and therapeutic drug monitoring to maintain efficacy.
• Oral contraceptives: Levetiracetam may slightly decrease hormonal contraceptive effectiveness; advise additional or alternative birth control methods.